Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia.
Bouligny IM, Murray G, Doyel M, Patel T, Boron J, Tran V, Gor J, Hang Y, Alnimer Y, Ho T, Zacholski K, Venn C, Wages NA, Grant S, Maher KR.
Bouligny IM, et al. Among authors: maher kr.
Med Oncol. 2024 Feb 23;41(3):80. doi: 10.1007/s12032-024-02302-y.
Med Oncol. 2024.
PMID: 38396145